[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f2or7u5mlmntc4":3,"organisation-32159547-bcff-4bce-b024-4272255a7cf6":5,"organisation-articles-32159547-bcff-4bce-b024-4272255a7cf6":8},{"hasError":4,"data":5},true,{"description":6,"errorCode":7},"resource does not exist",404,[9],{"id":10,"title":11,"pubDate":12,"logoUrl":13,"thirdParty":14,"orgId":15,"branches":16,"description":20},"f1567d02-3b79-45e1-b02e-83a28d88e33f","ZIN geeft positief advies over vergoeding Oncotype DX Breast Recurrence Score® test","2021-09-13T07:00:00.061+02:00","https:\u002F\u002Fwww.persberichten.nl\u002Ffile\u002Flogos\u002F32159547-bcff-4bce-b024-4272255a7cf6\u002Fa5ac1efa-1fce-481d-80a6-a26f5f856a09.jpg",false,"32159547-bcff-4bce-b024-4272255a7cf6",[17],{"id":18,"title":19},"29100","Zorg","Zorg Instituut Nederland (ZIN) geeft positief advies voor vergoeding van de Oncotype DX Breast Recurrence Score® test Amsterdam, september 2021 - Exact Sciences"]